Xenetic Biosciences (XBIO) Interest Coverage Ratio (2011 - 2026)
Xenetic Biosciences' (XBIO) quarterly Interest Coverage Ratio came in at 0.01 in Q1 2026, up 44.72% YoY from 0.01 in Q1 2025, and up 3.67% on a QoQ basis from 0.01 in Q3 2025.
Xenetic Biosciences (XBIO) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 16 years of Interest Coverage Ratio data on file, last reported at 0.01 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 44.72% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (up 35.95% YoY) and the FY2025 annual result came in at 0.07, up 30.33% from the prior year.
- Interest Coverage Ratio climbed to 0.01 in Q1 2026, from 0.01 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.01 in Q3 2024 to a low of 57.81 in Q4 2022.
- A 5-year average of 4.16 and a median of 0.03 in 2022 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 71.36% in 2022, down 120.75% in 2022.
- Tracing XBIO's Interest Coverage Ratio over 5 years: stood at 57.81 in 2022, then surged by 99.95% to 0.03 in 2023, then surged by 57.94% to 0.01 in 2024, then retreated by 6.18% to 0.01 in 2025, then advanced by 3.67% to 0.01 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q3 2025), and 0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 1.42 |
| 10 | Xenetic Biosciences | 7.30 Mn | 824,311.67 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02 |
| Mar 31, 2026 | -0.01 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -57.81 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -201.88 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.05 |
| Dec 31, 2020 | -43.45 |